BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6784745)

  • 1. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
    Thom MH; Collins WP; Studd JW
    Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absorption and metabolism of oral oestradiol, oestrone and oestriol.
    Townsend PT; Dyer GI; Young O; Whitehead MI; Collins WP
    Br J Obstet Gynaecol; 1981 Aug; 88(8):846-52. PubMed ID: 6789863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal profiles after the menopause.
    Chakravarti S; Collins WP; Forecast JD; Newton JR; Oram DH; Studd JW
    Br Med J; 1976 Oct; 2(6039):784-7. PubMed ID: 974609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
    Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
    Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
    Fåhraeus L; Larsson-Cohn U
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oestrogens in postmenopausal women with endometrial cancer.
    Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Hagen C; Haug E
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L; Naessén T; Eriksson K; Rune C
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results.
    Burger HG; Hailes J; Menelaus M; Nelson J; Hudson B; Balazs N
    Maturitas; 1984 Dec; 6(4):351-8. PubMed ID: 6442755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
    Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
    Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.
    Suhonen S; Sipinen S; Lähteenmäki P; Laine H; Rainio J; Arko H
    Maturitas; 1993 Mar; 16(2):123-31. PubMed ID: 8483424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of luteinizing hormone and follicle-stimulating hormone during anoestrus in ewes actively immunized against oestradiol-17 beta, oestrone or testosterone.
    Martensz ND; Scaramuzzi RJ; Van Look PF
    J Endocrinol; 1979 Jun; 81(3):261-9. PubMed ID: 572861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
    Isaacs AJ; Havard CW
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    Englund DE; Johansson ED
    Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
    Towobola OA; Crilly RC; Oakey RE
    Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exposure to long days on the secretion of oestradiol, oestrone, progesterone, testosterone, androstenedione, cortisol and follicle-stimulating hormone in intact and spayed ferrets.
    Donovan BT; Matson C; Kilpatrick MJ
    J Endocrinol; 1983 Dec; 99(3):361-8. PubMed ID: 6417256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.